Life quality tracked for frail leukemia patients on new drug combo
NCT ID NCT06181734
Summary
This study observed how a specific drug combination affects the quality of life and daily reality for older adults with a certain type of acute myeloid leukemia (AML) who cannot tolerate standard chemotherapy. Researchers followed 8 patients in Germany to see how they felt and functioned during treatment, while also tracking survival and safety. The goal was to understand the real-world benefits and challenges of this treatment approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Praxis für interdisziplinäre Onkologie & Hämatologie
Freiburg im Breisgau, Germany
Conditions
Explore the condition pages connected to this study.